Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Anlon Healthcare Ltd

NSE: AHCL · BSE: 544497 · Pharmaceuticals & Biotechnology · 43 announcements

Share price
₹28.18
Market cap
₹149.8 Cr
Revenue (annual)
₹172.0 Cr
Net profit (annual)
₹28.51 Cr
P/E (TTM)
4.7×Sector 47.3×
Promoter holding
52.68%+0.00% QoQ
FII holding
1.67%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

15:08 IST NSE
Merger & Restructuring

Anlon Healthcare Merger & Restructuring

Anlon Healthcare incorporated ANLON Healthcare Nigeria Limited, holding 90% stake. The subsidiary aims to expand pharmaceutical and healthcare operations across 16 West African countries.

20:32 IST NSE
Merger & Restructuring

Anlon Healthcare Merger & Restructuring Worth ₹153.3 Cr

Anlon Healthcare will acquire significant stakes in Apiqo Organics (44.94%) and Bizotic Lifescience (47.41%) for a total consideration of approximately ₹153.30 Crore. Acquisitions involve a share swap via preferential issue.

Value
₹153.3 Cr
18:00 IST BSE
Merger & Restructuring

Anlon Healthcare Merger & Restructuring Worth ₹116.5 Cr

Anlon Healthcare executed agreements to acquire stakes in Apiqo Organics and Bizotic Lifescience via share swaps. The AOPL acquisition is valued at approximately ₹116.52 Crore.

Value
₹116.5 Cr
16:17 IST BSE
Merger & Restructuring

Anlon Healthcare Merger & Restructuring Worth ₹0.07 Cr

Anlon Healthcare incorporated a 65% subsidiary, Anlon Biologics Private Limited, for Rs. 0.065 Crore. The unit will manufacture surgical implants and biosimilars.

Value
₹0.07 Cr
20:28 IST NSE
Merger & Restructuring

Anlon Healthcare Merger & Restructuring Worth ₹0.11 Cr

Anlon Healthcare incorporated a 55% subsidiary, Anlon Medicare Private Limited, for Rs. 0.11 Crore. The new unit will manufacture surgical implants and medical devices.

Value
₹0.11 Cr